Cargando…
Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Gene transfer to and correction of hematopoietic stem cells (HSCs) are ideal strategies to cure a number of congenital and acquired disorders. However, transgene products may trigger immunological rejection of modified cells, limiting their therapeutic benefits. Preclinical and clinical data indicat...
Autores principales: | Drysdale, Claire M., Tisdale, John F., Uchida, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859277/ https://www.ncbi.nlm.nih.gov/pubmed/31763350 http://dx.doi.org/10.1016/j.omtm.2019.10.010 |
Ejemplares similares
-
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
por: Demirci, Selami, et al.
Publicado: (2020) -
Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
por: Demirci, Selami, et al.
Publicado: (2020) -
Immunoresponsiveness in endometriosis: implications of estrogenic toxicants.
por: Rier, S E, et al.
Publicado: (1995) -
Immunoresponsive gene 1 modulates the severity of brain injury in cerebral ischaemia
por: Kuo, Ping-Chang, et al.
Publicado: (2021) -
Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection
por: Hayakawa, Jun, et al.
Publicado: (2009)